表紙
市場調査レポート

虚血性脳卒中:世界の治験レビュー

Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 308776
出版日 ページ情報 英文 85 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
虚血性脳卒中:世界の治験レビュー Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014
出版日: 2014年07月21日 ページ情報: 英文 85 Pages
概要

当レポートでは、虚血性脳卒中に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

イントロダクション

  • 虚血性脳卒中
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する虚血性脳卒中の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系の治験件数に対する虚血性脳卒中の治験件数比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

虚血性脳卒中治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Stempeutics Research Private Limited
    • Neurobiological Technologies, Inc.
    • Grifols, S.A.
    • D-Pharm Ltd.
    • Celgene Corporation
  • 代表的な研究機関・病院の治験の概要
    • Bad Aibling Neurological Clinic
    • Department of Health, South Africa
    • Taipei Medical University WanFang Hospitall
    • University of Rostock
    • 徳島大学
    • University Medical Center Hamburg-Eppendorf
    • Baqiyatallah Medical Sciences University
    • 慶應大学
    • Erasmus MC
    • University Hospital, Lille

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2243CTIDB

GlobalData's clinical trial report, "Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cerebral Stroke clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cerebral Stroke. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Cerebral Stroke. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ischemic Cerebral Stroke
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Ischemic Cerebral Stroke to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ischemic Cerebral Stroke to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ischemic Cerebral Stroke
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ischemic Cerebral Stroke Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Stempeutics Research Private Limited
      • Clinical Trial Overview of Stempeutics Research Private Limited
      • Neurobiological Technologies, Inc.
      • Clinical Trial Overview of Neurobiological Technologies, Inc.
      • Grifols, S.A.
      • Clinical Trial Overview of Grifols, S.A.
      • D-Pharm Ltd.
      • Clinical Trial Overview of D-Pharm Ltd.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • Bad Aibling Neurological Clinic
      • Clinical Trial Overview of Bad Aibling Neurological Clinic
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • Taipei Medical University WanFang Hospital
      • Clinical Trial Overview of Taipei Medical University WanFang Hospital
      • University of Rostock
      • Clinical Trial Overview of University of Rostock
      • The University of Tokushima
      • Clinical Trial Overview of The University of Tokushima
      • University Medical Center Hamburg-Eppendorf
      • Clinical Trial Overview of University Medical Center Hamburg-Eppendorf
      • Baqiyatallah Medical Sciences University
      • Clinical Trial Overview of Baqiyatallah Medical Sciences University
      • Keio University
      • Clinical Trial Overview of Keio University
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • University Hospital, Lille
      • Clinical Trial Overview of University Hospital, Lille
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Ischemic Cerebral Stroke to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ischemic Cerebral Stroke to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ischemic Cerebral Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurobiological Technologies, Inc., 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by D-Pharm Ltd., 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Bad Aibling Neurological Clinic, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokushima, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Hamburg-Eppendorf, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Baqiyatallah Medical Sciences University, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Lille, 2014*

List of Figures

  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Ischemic Cerebral Stroke to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ischemic Cerebral Stroke to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ischemic Cerebral Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top